NBC Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$699K Sell
1,327
-2
-0.2% -$1.12K 0.05% 406
2026
Q1
$747K Buy
1,329
+21
+2% +$13.5K 0.06% 355
2025
Q4
$885K Sell
1,308
-52
-4% -$35.4K 0.07% 310
2025
Q3
$869K Buy
1,360
+25
+2% +$15.2K 0.07% 317
2025
Q2
$716K Buy
1,335
+808
+153% +$386K 0.06% 365
2025
Q1
$221K Buy
+527
New +$229K 0.02% 742
2024
Q4
Sell
-721
Closed -$364K 1637
2024
Q3
$364K Buy
721
+18
+3% +$8.74K 0.03% 577
2024
Q2
$342K Buy
703
+131
+23% +$65.8K 0.03% 565
2024
Q1
$318K Sell
572
-10
-2% -$5.46K 0.03% 581
2023
Q4
$323K Buy
582
+29
+5% +$13.6K 0.03% 553
2023
Q3
$241K Buy
+553
New +$276K 0.03% 623

Other funds holding IDXX

NBC Securities's IDXX Position: Q2 2026 in Review

NBC Securities reduced its Idexx Laboratories (IDXX) stake by 0.15% in Q2 2026, selling an estimated $1.12K and leaving 1,327 shares worth $699K. The position accounts for 0.05% of the portfolio, ranked #406.

NBC Securities first reported a position in IDXX in Q3 2023 and has held it in 11 quarters since. The position peaked at $885K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • NBC Securities held 1,327 shares of Idexx Laboratories worth $699K as of Q2 2026.
  • NBC Securities sold 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
  • Idexx Laboratories made up 0.05% of NBC Securities's portfolio in Q2 2026, its #406 holding.
  • NBC Securities first reported a position in Idexx Laboratories in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Idexx Laboratories position peaked at $885K in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.